A single-centre retrospective study assessing Tofacitinib in patients with cutaneous and pulmonary sarcoidosis
Latest Information Update: 23 Oct 2020
At a glance
- Drugs Tofacitinib (Primary)
- Indications Pulmonary sarcoidosis; Sarcoidosis
- Focus Adverse reactions; Therapeutic Use
- 23 Oct 2020 New trial record
- 16 Oct 2020 Results published in the Journal of the American Academy of Dermatology